Recap: Oncolytics Biotech Q4 Earnings

Oncolytics Biotech ONCY reported its Q4 earnings results on Thursday, March 7, 2024 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Oncolytics Biotech beat estimated earnings by 64.0%, reporting an EPS of $-0.04 versus an estimate of $-0.11.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.0 which was followed by a 4.0% drop in the share price the next day.

To track all earnings releases for Oncolytics Biotech visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.